Pharmacy Daily | Chemotherapy

The announcement by the Federal Government of additional funding for the provision of chemotherapy medicines has been welcomed by the Guild. This commitment is important to ensure these vital medicines continue to be available for cancer patients. The Executive Director of the Guild, David Quilty, said the Guild appreciated that the Government had worked hard to find an interim solution to this matter at a time when the fiscal environment is extremely difficult. “We also welcome the fact that this interim funding has been found from outside the Community Pharmacy Agreement. “This means that the vast majority of community pharmacies which are not involved in the provision of chemotherapy medicines will not be disadvantaged,” Mr Quilty said. The new funding which will be provided from 1 July until 31 December is an acknowledgement that the viability of private chemotherapy service delivery had been put at risk by the impact of price disclosure cuts from last December on some chemotherapy drugs, and that previously cross-subsidised chemotherapy services were in danger of being rendered uneconomic. Mr Quilty commended the approach taken by the chemotherapy medicine providers over the past six months, as they continued to provide services for the benefit of patients.

---

The above article was sent to subscribers in Pharmacy Daily's issue from 07 May 13
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 May 13